Disease evidence hub
A curated view of published Tuberculosis research, auditable classifier relationships, and the available GIDS surveillance timeline.
Evidence timeline
The two bars use independent scales. Their alignment supports navigation and comparison only; it does not claim that publication activity explains surveillance activity.
Guidance and policy markers identify dated publications in the curated catalogue; they do not by themselves establish that an official policy changed on that date.
Evidence stream
30 of 131 publications shown
ACS Medicinal Chemistry Letters
Why it matters nowThe findings address antimicrobial resistance and limited treatment options for latent tuberculosis infection, which affects approximately 90% of infected individuals. The hypoxia-activated prodrug approach may improve treatment of persistent tuberculosis within hypoxic niches that drive prolonged treatment regimens.
International Journal of Infectious Diseases
Why it matters nowLatent tuberculosis infection remains common among healthcare workers, and positivity estimates vary substantially by diagnostic method. The association of TST positivity with BCG vaccination suggests IGRA may offer greater specificity for screening BCG-vaccinated occupational groups.
Public Health Reviews
Why it matters nowThe synthesis identifies priority interventions such as guideline updates and workforce training that address documented operational gaps. Enhancing these areas may improve overall disease management capacity within the region.
World Journal of Gastrointestinal Surgery
Why it matters nowThe findings describe a postoperative wound-healing burden and associated patient characteristics in an emergency intestinal-tuberculosis surgery cohort. They may provide contextual evidence for editorial assessment of surgical outcomes in this narrowly defined population, but they do not measure population-level disease activity or a surveillance trend.
Microbiology spectrum
Why it matters nowThe WHO mutation catalog is increasingly used for clinical decision-making, and false-resistant predictions for rifampin, delamanid, and pretomanid can lead to inappropriate treatment adjustments, highlighting the need for systematic quality control.
Frontiers in Cellular and Infection Microbiology
Why it matters nowThe findings suggest that peripheral double-positive T cell percentage could serve as a non-invasive biomarker for TB severity stratification, potentially supporting clinical decision-making in tuberculosis management.
PloS one
Why it matters nowThe findings identify specific TB knowledge gaps among future clinicians in a high-burden setting and may inform curricular reinforcement of TB-related knowledge, attitudes, and preventive practices.
Annals of African Medicine
Why it matters nowMonitoring these biological parameters could serve as an economical supplementary approach for evaluating therapeutic progression in healthcare systems with restricted infrastructure.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace
Why it matters nowThe findings underscore a viable procedural pathway for resolving diagnostically ambiguous pleural conditions in regions where infectious and neoplastic respiratory diseases carry substantial prevalence.
International Journal of Analysis and Applications
Why it matters nowThe quantitative comparisons assist decision-makers in balancing budgetary limits against the desired magnitude of case reduction during tuberculosis management.
Discovery Medicine
Why it matters nowThe authors argue that sustained declines in standardized LTBI rates co-exist with a growing absolute caseload, implying that TB elimination efforts require prevention-oriented policies targeting progression to active disease, especially in ageing and other high-risk populations.
BMC Infectious Diseases
Why it matters nowThe pronounced regional concentration of reported cases implies that precision resource deployment and area-specific prevention initiatives may better support national elimination objectives.
Wellcome Open Research
Why it matters nowThe compilation frames melioidosis as an escalating yet frequently ignored infectious threat that demands improved monitoring frameworks, uniform testing standards, and interdisciplinary coordination to decrease adverse health outcomes.
Social History of Medicine
Why it matters nowThe article highlights how segregation, poverty, and political structures can obstruct TB treatment, surveillance, and social-health interventions, even when curative medical technology is available.
The Indonesian Journal of General Medicine
Why it matters nowConventional imaging protocols frequently miss active infections in immunocompromised cohorts, aligning with the authors' emphasis on laboratory confirmation regardless of scan results.
Frontiers in Medicine
Why it matters nowPR may represent a non-pharmacologic intervention that could improve functional outcomes and quality of life in the substantial population living with long-term respiratory sequelae of tuberculosis.
Wellcome Open Research
Why it matters nowSanatorium-based tuberculosis care was acceptable to mobile migrant populations because it addressed structural and social barriers through free, trusted, and supportive care combined with practical assistance, enabling completion of prolonged treatment regimens.
Frontiers in Pediatrics
Why it matters nowThe report emphasizes the importance of early diagnosis, individualized treatment, and regular follow-up for patients with hyper-IgE syndrome given their susceptibility to severe infections and lymphoma.
Pediatrics
Why it matters nowThe case underscores the need for heightened awareness of tuberculosis during pregnancy, particularly in at-risk populations, to enable early diagnosis and prevent perinatal transmission. It highlights the diagnostic challenge posed by asymptomatic maternal TB and variable presentation in affected neonates.
Artificial Intelligence in Gastroenterology
Why it matters nowImproving detection accuracy for abdominal tuberculosis in resource-constrained environments could mitigate diagnostic delays and support more standardized care delivery pathways.
Microorganisms
Why it matters nowReducing diagnostic uncertainty for clinical laboratories could facilitate more consistent implementation of genomic resistance testing. Standardized predictive accuracy may support uniform laboratory reporting practices and improve workflow reliability.
Frontiers in Cellular and Infection Microbiology
Why it matters nowOvercoming current diagnostic delays and incomplete resistance profiling could improve laboratory efficiency and support more informed therapeutic planning for a persistent global infectious disease burden.
Microbial Genomics
Why it matters nowReducing reliance on lengthy culture procedures may accelerate pathogen genome recovery for epidemiological tracking.
mSystems
Why it matters nowThe abstract frames the work in relation to tuberculosis and HIV coinfection, noting that TB remains a major cause of mortality, particularly among people living with HIV. The study may be relevant to understanding pathogen evolution under immune and treatment-related pressures, but the supplied evidence is from a non-human primate model rather than a clinical intervention study.
npj Antimicrobials and Resistance
Why it matters nowThe findings are relevant to addressing the global burden of drug-resistant tuberculosis and the need for shorter, more effective treatment regimens.
mBio
Why it matters nowFindings suggest that pharmacological disruption of the bacterial pH gradient is a rapid chemical tool to study persister biology in TB, with potential broader relevance to other infectious diseases.
Frontiers in Cellular and Infection Microbiology
Why it matters nowDistinguishing spinal tuberculosis from pyogenic spondylitis is clinically important because the two conditions require different treatment approaches. The findings suggest that quantitative SPECT/CT parameters may offer complementary diagnostic information to improve differential diagnosis, though multicenter validation and prospective studies are needed before clinical implementation.
Research Connections
Why it matters nowThe article positions viral hepatitis as an urgent public health priority warranting immediate action through expanded testing, diagnosis, treatment, birth-dose vaccination, and integration with Universal Health Coverage initiatives.
BMC Infectious Diseases
Why it matters nowThe authors frame the findings as relevant to advancing WHO End TB targets in Saudi Arabia, calling for strengthened surveillance, targeted screening, and region-specific interventions.
Journal of Public Health and Primary Care
Why it matters nowThe paper raises ethical and policy concerns about tuberculosis preventive therapy in regions with high drug resistance, potentially informing TPT guidelines and harm-benefit assessments for latent TB treatment.
